Your browser doesn't support javascript.
loading
Expert opinion on the use of contraception in people with multiple sclerosis.
Hillert, Jan; Bove, Riley; Haddad, Lisa B; Hellwig, Kerstin; Houtchens, Maria; Magyari, Melinda; Merki-Feld, Gabriele S; Montgomery, Scott; Nappi, Rossella E; Stenager, Egon; Thompson, Heidi; Tulek, Zeliha; Verdun Di Cantogno, Elisabetta; Simoni, Manuela.
Afiliação
  • Hillert J; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Bove R; UCSF Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.
  • Haddad LB; Center for Biomedical Research, Population Council, New York, NY, USA.
  • Hellwig K; Katholisches Klinikum Bochum GmbH, Nordrhein-Westfalen, Bochum, Germany.
  • Houtchens M; Brigham and Women's Hospital, Boston, MA, USA/ Harvard Medical School, Boston, MA, USA.
  • Magyari M; Danish Multiple Sclerosis Center, University Hospital Boston, MA, USA/ Rigshospitalet, Copenhagen, Denmark.
  • Merki-Feld GS; Clinic of Reproductive Endocrinology, University Hospital Zürich, Zürich, Switzerland.
  • Montgomery S; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Nappi RE; Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Stenager E; Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy.
  • Thompson H; Research Center of Reproductive Medicine, IRCCS San Matteo Foundation, Pavia, Italy.
  • Tulek Z; Department of Regional Research, University of Southern Denmark, Odense, Denmark.
  • Verdun Di Cantogno E; MS-Clinic of Southern Jutland (Aabenraa, Esbjerg, Kolding), Sønderborg, Denmark.
  • Simoni M; Southern Health & Social Care Trust, Portadown, Northern Ireland.
Mult Scler ; : 13524585241228103, 2024 Mar 08.
Article em En | MEDLINE | ID: mdl-38456514
ABSTRACT

BACKGROUND:

Current guidance on the selection of appropriate contraception for people with multiple sclerosis (PwMS) is lacking.

OBJECTIVE:

To address this gap, an expert-led consensus program developed recommendations to support clinicians in discussing family planning and contraception with women and men with multiple sclerosis (MS).

METHODS:

A multidisciplinary steering committee (SC) of 13 international clinical experts led the program, supported by an extended faculty of 32 experts representing 18 countries. A modified Delphi methodology was used for decision-making and consensus-building. The SC drafted 15 clinical questions focused on patient-centered care, selection of contraception, and timing of stopping/starting contraception and disease-modifying therapies (DMTs). Statements addressing each question were drafted based on evaluation of published evidence and the experts' clinical experience. Consensus was reached if ⩾75% of respondents agreed (scoring 7-9 on a 9-point scale) with each recommendation.

RESULTS:

Consensus was reached on 24 of 25 proposed recommendations, including how and when to discuss contraception, types and safety of contraceptives, and how to evaluate the most appropriate contraceptive options for specific patient groups, including those with significant disability or being treated with DMTs.

CONCLUSION:

These expert recommendations provide the first practical, relevant, and comprehensive guidance for clinicians on the selection of contraception in PwMS.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article